A Stent-Free Future for Common Cardiovascular Ailments
A team of researchers is developing a new approach for maintaining open blood vessels in the wake of surgeries such as angioplasties or bypasses.
Tag: nanotechnology
Advances in nanotechnology have important implications for tissue engineering, gene editing, precision medicine, and more.
For instance, WID scientists are advancing the science and engineering of manufacturing scaffolds with the aid of nanotechnology. These scaffolds will give cells a place to adhere while dividing, communicating, absorbing nutrients, and disposing of waste. The scaffolds will also provide a platform for various drug delivery modes.
WID Researchers Looking to the Future with UW2020 Awards
Investigators from WID are among the recipients of the latest round of UW2020 awards.
Undergraduate Nathan Wang Receives Goldwater Scholarship
The scholarship recognizes promising undergraduates who plan to pursue a PhD or MD/PhD followed by a research career in engineering, mathematics, or the natural sciences.
Small But Mighty: Nanoparticles Can Deliver More Types of Drugs, More Safely
WID researcher Shaoqin Sarah Gong is working to more safely deliver a variety of drugs to treat cancer, heart disease and even blindness.
Xin-Yi (Vivien) Wang
Visiting Scholar, Turng Lab
Tissue engineering 3-D scaffolds and self-healing hydrogels
All-in-One Repair Kit Makes CRISPR Gene Editing More Precise
Error rates as high as 50 percent are a problem when the goal is to correct typos in the DNA that cause genetic disease. Now, a team of researchers led by WID’s Kris Saha has made the fix less mistake-prone.
Yi Shiuan Li
Visiting Scholar, Turng Group
Mechanical characteristic investigation on polishing pads used in Chemical Mechanical Planarization
Randolph Ashton Continues Research into Causes of Lou Gehrig’s Disease
In August 2017, Randolph Ashton received almost $800,000 from the National Institute of Neurological Disorders and Stroke, part of NIH, to continue a five-year research study of Lou Gehrig’s disease (amyotrophic lateral sclerosis, or ALS), after successfully completing its first phase.
UW-Madison to be Partner in Center for Cell Manufacturing Technologies
The National Science Foundation has awarded nearly $20 million to a consortium of universities to support a new engineering research center that will develop transformative tools and technologies for the consistent, scalable, and low-cost production of high-quality living therapeutic cells. Several WID investigators are collaborators on the project.
Qifeng Zheng
Postdoc, Gong Lab
Engineering Polymer Nanocomoposite Aerogels for Energy Storage and Harvesting
Suiyi Li
Visiting Scholar, Turng Lab
Bamboo charcoal/ultra high molecular weight polyethylene composites for artificial joint application
Wendy Crone
Karen Thompson Medhi Professor
Solid mechanics, nanotechnology, and biotechnology
Sridharan Lab
The main scientific focus of the lab is in defining how the epigenome controls pluripotency. Pluripotent stem cells can differentiate into any cell type; gene regulation, controlled by the unique epigenetics of iPS cells, has to be plastic to maintain the cellular identity of a stem cell but also to be responsive to differentiation cues.
Saha Human Stem Cell Engineering Lab
By bringing together stem cell biology, genome engineering, and biomaterials expertise, the Saha lab generates new tools for use with human-induced pluripotent stem cells to ask unique questions about human biology and disease.